2008 | | The Validity and Reliability of the Korean Version of Revised Processes of Change for Weight Control Scale in Adults with Metabolic Syndrome | 김대중, 김춘자, 채선미 |
2005 | | Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas. | 김대중, 이관우 |
2014 | | Toxicity generated through inhibition of pyruvate carboxylase and carnitine palmitoyl transferase-1 is similar to high glucose/palmitate-induced glucolipotoxicity in INS-1 beta cells. | 강엽, 김대중, 김혜진, 이관우, 이수진, 최성이, 한승진 |
2016 | | Trends in Diabetes Incidence in the Last Decade Based on Korean National Health Insurance Claims Data | 김대중 |
2015 | | Trends in the Diabetes Epidemic in Korea. | 김대중, 하경화 |
2016 | | Trends in the Impact of Diabetes on the Development of Cardiovascular Diseases | 김대중, 하경화 |
2016 | | Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study | 김대중 |
2016 | | Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes | 김대중, 하경화 |
2015 | | Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 김대중 |
2011 | | Utilization patterns and cost of complementary and alternative medicine compared to conventional medicine in patients with type 2 diabetes mellitus. | 김대중, 김혜진, 이관우, 전기홍, 한승진 |
2019 | | Utilization patterns of insulin for patients with type 2 diabetes from national health insurance claims data in South Korea | 김대중 |
2015 | | VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases. | 김대중, 김장희, 소의영, 신승수, 이기범, 이정훈, 임현이, 정선용, 정윤석, 한재호 |
2016 | | Visceral Fat Mass Has Stronger Associations with Diabetes and Prediabetes than Other Anthropometric Obesity Indicators among Korean Adults | 김대중, 하경화 |
2012 | | β-Cell-protective effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid as a glutamate dehydrogenase activator in db/db mice | 강엽, 김대중, 김혜진, 이관우, 한승진 |
2007 | | 청소년 제2형 당뇨병환자의 심혈관질환 예방 | 김대중 |